These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


319 related items for PubMed ID: 25727592

  • 1. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA, Sachdev N, Staffieri SE, McKenzie JD, Elder JE.
    J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
    [Abstract] [Full Text] [Related]

  • 2. Advanced unilateral retinoblastoma: a case of sparing enucleation treatment failure.
    Valente P, De Ioris MA, Romanzo A, Cozza R, Natali G, Buzzonetti L.
    Can J Ophthalmol; 2016 Apr; 51(2):e40-3. PubMed ID: 27085272
    [No Abstract] [Full Text] [Related]

  • 3. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 4. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH.
    Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
    [Abstract] [Full Text] [Related]

  • 5. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, Upadhyaya A, Azad R.
    Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
    [Abstract] [Full Text] [Related]

  • 6. Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
    Kim JH, Yu YS, Khwarg SI, Choi HS, Shin HY, Ahn HS.
    Korean J Ophthalmol; 2003 Jun; 17(1):35-43. PubMed ID: 12882506
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH.
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
    Dimaras H, Khetan V, Halliday W, Héon E, Chan HS, Gallie BL.
    Arch Ophthalmol; 2009 Aug; 127(8):1066-8. PubMed ID: 19667353
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.
    Pavlidou E, Burris C, Thaung C, Scheimberg I, Kingston J, Hungerford JL, Reddy MA, Sagoo MS.
    JAMA Ophthalmol; 2015 Dec; 133(12):1455-8. PubMed ID: 26334520
    [Abstract] [Full Text] [Related]

  • 18. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA.
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.